se of two different Ayurvedic compound formulation in Shwasa Roga (Bronchial Asthma)

Phase 1

Completed

• Conditions: Health Condition 1: J453- Mild persistent asthmaHealth Condition 2: null- Tamaka Swasa (Bronchial Asthma)

• Registration Number: CTRI/2015/08/006141
• Lead Sponsor: IPGTRA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-04-30
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 103

Inclusion Criteria

Patients having classical signs and symptoms of Tamaka Swasa like breathlessness, wheeze etc.Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.Symptoms/exacerbation (Wheeze, cough and breathlessness) greater than weekly and less than daily in frequency.Night symptoms twice per month but less than once a week.

Exclusion Criteria

Age more than 60 years and below 16 years.Mild intermittent, Moderated persistent, severe persistent to severe Asthma.Dyspnoea resulting from other diseases like left ventricular failure, COPD (Chronic Bronchitis, Emphysema), upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc.

Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions.

Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded.

HIV positive cases.

Pregnant/lactating mother.

Patients who need Salbutamol inhaler daily.

Patients having classical symptoms of Maha, Urdha, Chhinna and Kshudra Shwasa.

Study & Design

• Study Type: Interventional
• Study Design: Not specified